Talk:COVID-19 testing: Difference between revisions

Content deleted Content added

Inline

Revision as of 06:51, 4 October 2021

This is the talk page for discussing improvements to the COVID-19 testing article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: Index, 1, 2, 3: 7 days

WikiProject COVID-19 consensus

WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page.

General

Superseded by TfD October 2020 and later practice - consult regular {{Current}} guidance.

Refrain from using Worldometer (worldometers.info) as a source due to common errors being observed as noted on the Case Count Task Force common errors page. (April 2020, April 2020)

For infoboxes on the main articles of countries, use Wuhan, Hubei, China for the origin parameter. (March 2020)

"Social distancing" is generally preferred over "physical distancing". (April 2020, May 2020)

Page title

COVID-19 (full caps) is preferable in the body of all articles, and in the title of all articles/category pages/etc.(RM April 2020, including the main article itself, RM March 2021).

SARS-CoV-2 (exact capitalisation and punctuation) is the common name of the virus and should be used for the main article's title, as well as in the body of all articles, and in the title of all other articles/category pages/etc. (June 2022, overturning April 2020)

Map

There is no consensus about which color schemes to use, but they should be consistent within articles as much as possible. There is agreement that there should be six levels of shading, plus gray for areas with no instances or no data. (May 2020)

There is no consensus about whether the legend, the date, and other elements should appear in the map image itself. (May 2020)

For map legends, ranges should use fixed round numbers (as opposed to updating dynamically). There is no consensus on what base population to use for per capita maps. (May 2020)

To ensure you are viewing the current list, you may wish to purge this page.

This article has not yet been rated on Wikipedia's content assessment scale.
It is of interest to multiple WikiProjects.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

COVID-19 B‑class High‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Medicine: Pulmonology B‑class High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.
	This article is supported by the Pulmonology task force (assessed as Low-importance).

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Molecular Biology B‑class Low‑importance

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Low	This article has been rated as Low-importance on the importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Disaster management B‑class Low‑importance

	This article is within the scope of WikiProject Disaster management, a collaborative effort to improve the coverage of Disaster management on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Disaster managementWikipedia:WikiProject Disaster managementTemplate:WikiProject Disaster managementDisaster management articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Low	This article has been rated as Low-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Viruses B‑class Low‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Low	This article has been rated as Low-importance on the project's importance scale.

Other talk page banners

Text and/or other creative content from COVID-19 testing was copied or moved into Development of COVID-19 tests. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

This article was the subject of a Wiki Education Foundation-supported course assignment, between 3 April 2020 and 10 June 2020. Further details are available on the course page. Student editor(s): Elisawulfsberg (article contribs).

Section sizes

Section size for COVID-19 testing (60 sections)
Section name	Byte count	Section total
(Top)	8,178	8,178
Methods	2,895	70,222
Detection of the virus	1,289	34,163
Reverse transcription polymerase chain reaction (RT-PCR) test	21,691	21,691
Other molecular tests	1,745	1,745
Antigen tests	9,438	9,438
Antibody tests	7,358	17,608
Antibody Test Types	30	2,561
Rapid diagnostic test (RDT)	814	814
Enzyme-linked immunosorbent assay (ELISA)	561	561
Neutralization assay	434	434
Chemiluminescent immunoassay	722	722
Neutralizing vis-à-vis binding antibodies	7,689	7,689
Other tests	19	15,556
Sniff tests	2,274	2,274
Imaging	8,173	8,173
Serology (CoLab score) tests	948	948
Breath tests	244	244
Animals	3,273	3,273
Functional assays	625	625
History	7,537	7,537
Testing protocols	25	24,869
Drive-through testing	1,978	1,978
Home collection	2,364	2,364
Pooled testing	8,060	8,060
Multi-tiered testing	702	702
Required volume	1,068	5,615
United States	4,547	4,547
Snapshot mass-testing	2,770	2,770
Surveillance and screening of populations	3,355	3,355
Available tests	259	13,773
Nucleic acid tests	3,174	3,174
Antigen tests	4,739	4,739
Serology (antibody) tests	5,601	5,601
Accuracy	2,025	15,505
Sensitivity and specificity	2,922	2,922
Causes of test error	907	907
PCR-based test	8,349	8,349
Isothermal nucleic amplification test	1,302	1,302
Confirmatory testing	2,100	2,100
National or regional responses	36	38,314
Iceland	629	629
India	77	77
Italy	691	691
Japan	15,022	15,022
Russia	1,252	1,252
Singapore	773	773
Slovakia	859	859
South Korea	10,463	10,463
Taiwan	2,185	2,185
United Arab Emirates	991	991
United States	70	5,336
New York State	2,899	2,899
USS Theodore Roosevelt	1,335	1,335
Nevada	1,032	1,032
Testing statistics by country	1,729	1,729
See also	279	279
References	188	188
Further reading	1,971	1,971
External links	461	461
Total	185,126	185,126

Incorrect test specificity definition

Under methods > Reverse transcription polymerase chain reaction test the following statement is made: "The term sensitivity refers to the capacity of a test to identify all infected people, while specificity is the ability of a test to detect a particular virus"

This is not the common meaning of specificity, and even if it is used this way in the source, it will still confuse readers.

Proposed change: "The term sensitivity refers to the capacity of a test to identify all infected people, while specificity is the ability of a test to detect those that are not infected." — Preceding unsigned comment added by 2601:184:4781:2DA0:6040:8368:C30D:5C1A (talk) 15:27, 9 April 2021 (UTC)[reply]

Semi-protected edit request on 25 May 2021

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

Change "Use Commonwealth English" to "EngvarB" per tfd outcome Wikipedia:Templates_for_discussion#To_convert 81.2.252.231 (talk) 03:02, 25 May 2021 (UTC)[reply]

Done Run n Fly (talk) 18:34, 25 May 2021 (UTC)[reply]

Semi-protected edit request on 17 August 2021

This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request.

Immediately after "Antibody tests The body responds to a viral infection by producing antibodies that [help: delete "help"] neutralize the virus."[X] and

""Neutralization assay Neutralization assays assess whether sample antibodies prevent viral infection in test cells." [X]

it would be helpful for readers who do not know much about virus neutralization to cite:

Klasse PJ. Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives. Adv Biol. 2014;2014:157895. doi: 10.1155/2014/157895. Epub 2014 Sep 9. PMID: 27099867; PMCID: PMC4835181.

Likewise after the following passage, it would clarify the issue by adding that comprehensive reference about virus neutralization in general in two places:

"A NAb is an antibody that defends a cell from an infectious particle by neutralizing its biological effects. Neutralization renders the particle no longer infectious or pathogenic.[76][X] A binding antibody binds to the pathogen but the pathogen remains infective; the purpose can be to flag the pathogen for destruction by the immune system.[77]"[X]

But that passage requires several fundamental corrections thus:

A NAb is an antibody that neutralizes the infectivity of a virus particle by blocking its attachment to or entry into a susceptible cell; enveloped viruses, like e.g. SARS-CoV-2, are neutralized by the blocking of steps in the replicative cycle up to and including membrane fusion [76][X]. A non-neutralizing antibody either does not bind to the crucial structures on the virus surface or binds but leaves the virus particle infectious; the antibody may still contribute to the destruction of virus particles or infected cells by the immune system.[77][X] Virus Neutralization (talk) 15:58, 17 August 2021 (UTC)[reply]

Done RFZYNSPY ^talk 00:23, 22 August 2021 (UTC)[reply]

Note: Thanks for the amazingly thorough and expert edits. Keep 'em coming, Virus Neutralization! RFZYNSPY ^talk 00:25, 22 August 2021 (UTC)[reply]

english project

3rd wave of Corona virus advantage and disadvantage 106.200.166.173 (talk) 16:16, 24 August 2021 (UTC)[reply]

"Methods" / "Available tests"

Section 1 on "Methods" and section 4 on "Available tests" partially overlap. I suggest that the general theoretical parts of section 4 should be merged into section 1. And details of specific tests could be moved from section 1 to section 4, or they could be discarded if they no longer seem to be notable. JonH (talk) 17:29, 3 October 2021 (UTC)[reply]

@@ Line 29: / Line 29: @@
 |indexhere=yes
 }}
-== National responses ==
-The {{alink|National responses}} section is poorly written: it's a random set of factoids about a random set of countries. The section should be rewritten or removed entirely. If anyone attempts to rewrite it, I suggest: (a) taking a global view instead of looking at countries separately (in other words, get rid of subsections); (b) focusing on different strategies chosen and major milestones achieved in deployment of tests instead of listing random data points. —&nbsp;[[User:UnladenSwallow|UnladenSwallow]] ([[User talk:UnladenSwallow|talk]]) 21:46, 8 April 2021 (UTC)
 == Incorrect test specificity definition ==